Merit Medical Systems, Inc. (MM3.F)

Compare

92.00

-2.00

(-2.13%)

As of 8:02:23 AM GMT+2. Market Open.

3 Reasons to Avoid MMSI and 1 Stock to Buy Instead

Since April 2020, the S&P 500 has delivered a total return of 121%. But one standout stock has doubled the market - over the past five years, Merit Medical Systems has surged 247% to $105.49 per share. Its momentum hasn’t stopped as it’s also gained 10% in the last six months, beating the S&P by 13.3%.

StockStory yesterday

MMSI
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now

Merit Medical's strong product portfolio raises optimism about the stock.

Zacks 3 days ago

MMSI
GE HealthCare's Latest Product Launch to Boost Cardiology Care

GEHC's latest commercial launch of Flyrcado and the grant of pass-through status by CMS aim to serve a wider patient pool across the United States.

Zacks 3 days ago

ABT

MMSI

MDT
Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD

Endoscopic anti-reflux therapy recognized as evidence-based approach to providing relief of GERD symptoms.SOUTH JORDAN, Utah, March 27, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the American Society for Gastrointestinal Endoscopy (ASGE) updated its guideline on the diagnosis and management of gastroesophageal reflux disease (GERD) to include Transoral Incisionless Fundoplication (TIF 2.0) and TIF 2.0 Consec

GlobeNewswire 7 days ago

MMSI
Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results

MMSI unveils 12-month efficacy data for WRAPSODY CIE, highlighting its advanced technology in vascular access maintenance and potential to improve patient outcomes.

Zacks 8 days ago

MMSI

MASI

CAH
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)

At 6 months, the WRAPSODY CIE achieved 89.8% and 72.6% target lesion primary patency and access circuit primary patency, respectively.At 12 months, the WRAPSODY CIE achieved 70.1% and 58.1% target lesion primary patency and access circuit primary patency, respectively. SOUTH JORDAN, Utah, March 25, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that the six-month results from the randomized arm of the WRAPSODY Arteri

GlobeNewswire 9 days ago

MMSI
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including ICU Medical (NASDAQ:ICUI) and its peers.

StockStory 10 days ago

ICUI

PEN

MMSI
Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership

SOUTH JORDAN, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced that Chairman and Chief Executive Officer, Fred Lampropoulos, will visit the Nasdaq MarketSite in Times Square to ring the opening bell on Wednesday, March 19, 2025. The ceremony begins at 9:15 A.M. (EDT) and the bell ringing takes place at 9:30 A.M. "Merit’s listing on Nasdaq for 35 years marks a significant milestone in our company’s history,” s

GlobeNewswire 16 days ago

MMSI
MMSI Announces Commencement of Patient Enrollment in PREEMIE Study

Merit Medical aims to improve care for vulnerable premature infants by evaluating the safety and efficacy of the Bloom Micro Occluder System for treating PDA in the specified patient pool.

Zacks 20 days ago

MMSI

BSX

ANGO
3 Small-Cap Stocks Skating on Thin Ice

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

StockStory 22 days ago

MMSI

PLNT
Merit Medical enrols first subject in trial of Bloom Micro Occluder System

The eligibility criteria of the study require patients to weigh between 600g and 2.5kg.

Medical Device Network 23 days ago

MMSI
First Patient Enrolled in Merit Medical’s PREEMIE Study

Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infantsSOUTH JORDAN, Utah, March 10, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced enrollment of the first patient in its multicenter, prospective study of the Bloom Micro Occluder System for the treatment of patent ductus arteriosus (PDA) in premature infants

GlobeNewswire 24 days ago

MMSI
Merit Medical Systems Full Year 2024 Earnings: EPS Misses Expectations

Merit Medical Systems ( NASDAQ:MMSI ) Full Year 2024 Results Key Financial Results Revenue: US$1.36b (up 7.9% from FY...

Simply Wall St. last month

MMSI
Q4 2024 Merit Medical Systems Inc Earnings Call

Q4 2024 Merit Medical Systems Inc Earnings Call

Thomson Reuters StreetEvents last month

MMSI
MMSI Stock Gains in Pre-Market Post Q4 Earnings Beat, Margins Up

Merit Medical benefits from revenue growth in both segments and all its product categories within its Cardiovascular unit in the fourth quarter of 2024.

Zacks last month

MMSI

BSX

CAH
Merit Medical Systems Inc (MMSI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Merit Medical Systems Inc (MMSI) reports a 9% revenue increase and a 67% surge in free cash flow, despite conservative EPS guidance for 2025.

GuruFocus.com last month

MMSI
Compared to Estimates, Merit Medical (MMSI) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks last month

MMSI
Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of 12.05% and 0.93%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

MMSI
Merit Medical: Q4 Earnings Snapshot

The South Jordan, Utah-based company said it had profit of 46 cents per share. Earnings, adjusted for non-recurring costs, were 93 cents per share. The results topped Wall Street expectations.

Associated Press Finance last month

MMSI
Merit Medical Systems’s (NASDAQ:MMSI) Q4 Sales Top Estimates

Medical device company Merit Medical Systems (NASDAQ:MMSI) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.4% year on year to $355.2 million. The company expects the full year’s revenue to be around $1.48 billion, close to analysts’ estimates. Its non-GAAP profit of $0.93 per share was 12.2% above analysts’ consensus estimates.

StockStory last month

MMSI

Performance Overview

Return	MM3.F	S&P 500 (^GSPC)
YTD	0.00%	-8.25%
1-Year	+38.35%	+4.84%
3-Year	+52.07%	+17.76%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Merit Medical Systems, Inc. (MM3.F)

3 Reasons to Avoid MMSI and 1 Stock to Buy Instead

Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now

GE HealthCare's Latest Product Launch to Boost Cardiology Care

Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD

Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results

Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch

Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership

MMSI Announces Commencement of Patient Enrollment in PREEMIE Study

3 Small-Cap Stocks Skating on Thin Ice

Merit Medical enrols first subject in trial of Bloom Micro Occluder System

First Patient Enrolled in Merit Medical’s PREEMIE Study

Merit Medical Systems Full Year 2024 Earnings: EPS Misses Expectations

Q4 2024 Merit Medical Systems Inc Earnings Call

MMSI Stock Gains in Pre-Market Post Q4 Earnings Beat, Margins Up

Merit Medical Systems Inc (MMSI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Compared to Estimates, Merit Medical (MMSI) Q4 Earnings: A Look at Key Metrics

Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates

Merit Medical: Q4 Earnings Snapshot

Merit Medical Systems’s (NASDAQ:MMSI) Q4 Sales Top Estimates

Performance Overview